FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

773879000: Antineoplastic therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726859011 Antineoplastic therapeutic role en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3726860018 Antineoplastic therapeutic role (role) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antineoplastic therapeutic role Is a Therapeutic role true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Methotrexate 25 mg/mL solution for injection Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab 5 mg/mL solution for infusion Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Cetuximab 5 mg/mL solution for infusion and/or injection Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Leuprorelin (as leuprorelin acetate) 5 mg prolonged-release subcutaneous implant Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Methotrexate 50 mg/mL solution for injection Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely interferon beta-1a 60 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Vinorelbine (as vinorelbine tartrate) 30 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely vinorelbine (as vinorelbine tartrate) 20 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Vinorelbine only product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Vinorelbine-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely everolimus 2 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely everolimus 3 milligram/1 each conventional release orodispersible tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely gimeracil 4.35 milligram and oteracil (as oteracil potassium) 11.8 milligram and tegafur 15 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only gimeracil and oteracil and tegafur (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing gimeracil and oteracil and tegafur (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Palbociclib 125 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only gimeracil and oteracil and tegafur in oral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Palbociclib 100 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Palbociclib 75 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Gimeracil- and oteracil- and tegafur-containing product in oral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tipiracil (as tipiracil hydrochloride) 8.19 milligram and trifluridine 20 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely tipiracil (as tipiracil hydrochloride) 6.14 milligram and trifluridine 15 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely mitomycin 40 milligram/1 vial powder for conventional release intravesical solution (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only mitomycin in intravesical dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely darolutamide 300 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely gilteritinib (as gilteritinib fumarate) 40 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely enzalutamide 40 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Mitomycin-containing product in intravesical dose form Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely glasdegib (as glasdegib maleate) 25 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Glasdegib (as glasdegib maleate) 100 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely cytarabine 100 milligram and daunorubicin 44 milligram/1 vial powder for conventional release solution for infusion (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine and daunorubicin only product Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing cytarabine and daunorubicin in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Cytarabine- and daunorubicin-containing product Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only cytarabine and daunorubicin in parenteral dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Gimeracil 5.8 mg and oteracil (as oteracil potassium) 15.8 mg and tegafur 20 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Selumetinib (as selumetinib hydrogen sulfate) 10 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely selumetinib (as selumetinib hydrogen sulfate) 25 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely acalabrutinib 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely pertuzumab 80 milligram/1 milliliter and trastuzumab 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Pertuzumab 60 mg/mL and trastuzumab 60 mg/mL solution for injection Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Pertuzumab and trastuzumab only product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Pertuzumab- and trastuzumab-containing product in parenteral dose form Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only pertuzumab and trastuzumab (medicinal product) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Pertuzumab- and trastuzumab-containing product Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely interferon alfa-2b (as ropeginterferon alfa-2b) 500 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Nilotinib (as nilotinib hydrochloride) 50 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluorouracil 5 milligram/1 gram and salicylic acid 100 milligram/1 gram conventional release cutaneous solution (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Fluorouracil and salicylic acid only product Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Everolimus 1 mg oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely fluorouracil 40 milligram/1 gram conventional release cutaneous cream (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Everolimus 2 mg dispersible oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Bortezomib 2.5 mg/mL solution for injection Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Everolimus 3 mg dispersible oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Everolimus 5 mg dispersible oral tablet Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Chlormethine only product in cutaneous dose form Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing only fluorouracil and salicylic acid in cutaneous dose form (medicinal product form) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Lenalidomide 7.5 mg oral capsule Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely chlormethine (as chlormethine hydrochloride) 160 microgram/1 gram conventional release cutaneous gel (clinical drug) Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)
Chlormethine-containing product in cutaneous dose form Plays role False Antineoplastic therapeutic role Inferred relationship Existential restriction modifier (core metadata concept)

Start Previous Page 17 of 17

This concept is not in any reference sets

Back to Start